ED50 of dexmedetomidine for reduction of emergence agitation incidence undergoing tonsillectomy or adenoidectomy in desflurane anesthesia in childre
Not Applicable
Completed
- Conditions
- Diseases of th respiratory system
- Registration Number
- KCT0000126
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
tonsillectomy or adenoidectomy
Exclusion Criteria
recent URI hx, heart or neurologic problem
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method emergece agitation
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms of dexmedetomidine reduce emergence agitation in pediatric desflurane anesthesia?
How does dexmedetomidine compare to standard-of-care agents for emergence agitation in tonsillectomy/adenoidectomy?
Are there specific biomarkers that predict response to dexmedetomidine in children undergoing tonsillectomy?
What adverse events are associated with dexmedetomidine in pediatric desflurane anesthesia and how are they managed?
What are the potential combination approaches with dexmedetomidine for managing emergence agitation in children?